Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Belinostat was approved in 2014 for relapsed or refractory peripheral T-cell lymphoma
InChi: InChI=1S/C16H16N2OS/c1-11-12(13-5-2-3-6-14(13)18-11)8-9-17-16(19)15-7-4-10-20-15/h2-7
ME0328 enhances CRISPR-Cas9-mediated HER2 mutation frequency
Sardomozide
2000 Aug 1
VU0134992 hydrochloride Catalog No.:M7369-2 Belinostat was approved in 2014VU0134992 hydrochloride is the first subtype preferring, orally active and selective Kir4. 1 potassium channel pore blocker, with an IC50 of 0. 97 M. VU0134992 hydrochloride is 9 fold selective for homomeric Kir4. 1 over Kir4. 1 5. 1 concatemeric channels (IC50=9 M) at 120 mV. Product information CAS Number: 1052515 91 9 Molecular Weight: 447. 84 Formula: C20H32BrClN2O2 Chemical Name: 2 (2 bromo 4 propan 2 ylphenoxy) N (2,2,6,6 tetramethylpiperidin 4
US$ 107.50
US$ 118.00
US$ 105.00
US$ 242.00
US$ 136.50